Nordiet diet tested as a natural way to ease IBD symptoms

NCT ID NCT07389161

Recruiting now Disease control Sponsor: Region Skane Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a Mediterranean-like diet called Nordiet can improve gut health and reduce inflammation in 160 teens and adults with Crohn's disease or ulcerative colitis. Participants will follow the diet for four weeks while researchers check changes in gut bacteria, disease activity, and quality of life. The goal is to see if diet alone can help manage IBD without changing other treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mediterranean-like diet (Nordiet)
What this could lead to: If it works, this could point toward a simple dietary approach to help manage IBD symptoms and reduce inflammation.
What could go wrong: This is a small, early-phase study with no control group, so results may not be conclusive. Diet changes alone may not be enough for moderate-to-severe disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MB CROHN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MB CROHN ULCERATIVE COLITIS (UC)

Contacts and locations

Locations

Skåne University Hospital
RECRUITING

Malmö, 21428, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.